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Background
Ukraine takes one of the leading places in the growth of
the epidemic of HIV infection/AIDS in Europe. Nowa-
days, more than 1.4% adult population is HIV infected.
All people who need, receive ARV therapy. Today
almost 12000 patients use it.
Purpose of the study
Specialists of the Kiev regional AIDS center made a
comparative evaluation of ARV therapy efficiency
among patients at the center during the first half of the
2008 and the same period of 2009. They analyzed a
number of virological and immunological faults in the
treatment of the patients, who use ARV therapy during
1 year.
Results
Number of tested patients:
- 924(2008)
- 952(2009)
Among them, number of patients who received ARV
therapy during 1 year:
- 170(2008)
- 169(2009)
Number of faults (both virological and immunological)
abs\% from all persons who received ARV therapy:
- 58\32%(2008)
- 53\31% (2009)
Structure and % of the faults to the whole number of
tested patients:
1. Only virological faults:
- 3\1%(2008)
- 2\1%(2009)
2. Only immunological faults:
- 41\24%(2008)
- 31\18%(2009)
3. Both virological and immunological faults:
- 14\7%(2008)
- 20\12%(2009)
All patients, who had both virological and immunologi-
cal faults of the therapy, were suggested to change the
scheme of the therapy. The effectiveness of these changes
was analyzed after 6 month by the same criteria:
￿ Detected viral load level
￿ CD4 cells level lower than 200 cells/ml.
Effective change of the scheme of the ARV therapy:
- 10\71% (2008)
- 12\60% (2009)
Faults of the changed scheme of the ARV therapy : - 3
\21%(2008)
- 7\35%(2009)
Conclusions
We can make a conclusion that in 2009 there were
more both virusological and immunological faults as a
result of the ARV therapy. It can be an evidence of the
increasing of the number of the resistant viruses which
are circulated in the population of HIV infected persons
in Ukraine. This conclusion can be confirmed by the
low effectiveness of the changing of the schemes ARV
therapy. It can be a probable evidence of the formation
of the multi-resistance variants of the viruses.
So this study shows the necessity of introduction of
the researches of virus’s resistance in the practice of
laboratory researches for HIV infected people, who
receive ARV therapy in Ukraine.
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